• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微囊化:一种用于控释给药的有前景的技术。

Microencapsulation: A promising technique for controlled drug delivery.

作者信息

Singh M N, Hemant K S Y, Ram M, Shivakumar H G

机构信息

Department of Pharmaceutics, JSS College of Pharmacy, SS Nagar, Mysore, Karnataka-570015, India.

出版信息

Res Pharm Sci. 2010 Jul;5(2):65-77.

PMID:21589795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3093624/
Abstract

MICROPARTICLES OFFER VARIOUS SIGNIFICANT ADVANTAGES AS DRUG DELIVERY SYSTEMS, INCLUDING: (i) an effective protection of the encapsulated active agent against (e.g. enzymatic) degradation, (ii) the possibility to accurately control the release rate of the incorporated drug over periods of hours to months, (iii) an easy administration (compared to alternative parenteral controlled release dosage forms, such as macro-sized implants), and (iv) Desired, pre-programmed drug release profiles can be provided which match the therapeutic needs of the patient. This article gives an overview on the general aspects and recent advances in drug-loaded microparticles to improve the efficiency of various medical treatments. An appropriately designed controlled release drug delivery system can be a foot ahead towards solving problems concerning to the targeting of drug to a specific organ or tissue, and controlling the rate of drug delivery to the target site. The development of oral controlled release systems has been a challenge to formulation scientist due to their inability to restrain and localize the system at targeted areas of gastrointestinal tract. Microparticulate drug delivery systems are an interesting and promising option when developing an oral controlled release system. The objective of this paper is to take a closer look at microparticles as drug delivery devices for increasing efficiency of drug delivery, improving the release profile and drug targeting. In order to appreciate the application possibilities of microcapsules in drug delivery, some fundamental aspects are briefly reviewed.

摘要

微粒作为药物递送系统具有多种显著优势,包括:(i)有效保护包封的活性剂免受(例如酶促)降解,(ii)能够在数小时至数月的时间内精确控制所载药物的释放速率,(iii)易于给药(与其他非肠道控释剂型,如大型植入物相比),以及(iv)可以提供符合患者治疗需求的理想、预编程的药物释放曲线。本文概述了载药微粒的一般方面和最新进展,以提高各种医学治疗的效率。一个设计得当的控释药物递送系统在解决与药物靶向特定器官或组织以及控制药物向靶部位的递送速率相关的问题方面可能会更胜一筹。口服控释系统的开发一直是制剂科学家面临的一项挑战,因为他们无法将该系统限制并定位在胃肠道的目标区域。在开发口服控释系统时,微粒药物递送系统是一个有趣且有前景的选择。本文的目的是更深入地研究微粒作为药物递送装置,以提高药物递送效率、改善释放曲线和药物靶向性。为了了解微胶囊在药物递送中的应用可能性,简要回顾了一些基本方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/a0df50bfb3b6/JRPS-5-65-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/95dae64dde4f/JRPS-5-65-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/ec97a415275b/JRPS-5-65-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/a0df50bfb3b6/JRPS-5-65-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/95dae64dde4f/JRPS-5-65-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/ec97a415275b/JRPS-5-65-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c60/3093624/a0df50bfb3b6/JRPS-5-65-g003.jpg

相似文献

1
Microencapsulation: A promising technique for controlled drug delivery.微囊化:一种用于控释给药的有前景的技术。
Res Pharm Sci. 2010 Jul;5(2):65-77.
2
Review Article: Fabricated Microparticles: An Innovative Method to Minimize the Side Effects of NSAIDs in Arthritis.综述文章:人造微粒:一种将非甾体抗炎药在关节炎中的副作用降至最低的创新方法。
Crit Rev Ther Drug Carrier Syst. 2016;33(5):433-488. doi: 10.1615/CritRevTherDrugCarrierSyst.2016016624.
3
Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin.微粒、微囊和微球:胰岛素口服递送的最新进展及前景综述。
Int J Pharm. 2018 Feb 15;537(1-2):223-244. doi: 10.1016/j.ijpharm.2017.12.036. Epub 2017 Dec 26.
4
Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo.壳聚糖-海藻酸盐微胶囊为靶向细胞间黏附分子-1的纳米载体提供胃保护和肠道释放功能,实现体内胃肠道靶向。
Adv Funct Mater. 2016 May 24;26(20):3382-3393. doi: 10.1002/adfm.201600084. Epub 2016 Apr 23.
5
Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.开发pH和时间依赖性口服微粒以优化布地奈德向回肠和结肠的递送。
Int J Pharm. 2007 Jun 29;338(1-2):238-47. doi: 10.1016/j.ijpharm.2007.02.015. Epub 2007 Feb 16.
6
High precision microfluidic microencapsulation of bacteriophages for enteric delivery.用于肠道递送的噬菌体的高精度微流控微囊化
Res Microbiol. 2018 Nov;169(9):522-530. doi: 10.1016/j.resmic.2018.05.011. Epub 2018 Jun 7.
7
An Overview of Microparticulate Drug Delivery System and its Extensive Therapeutic Applications in Diabetes.微颗粒药物递送系统概述及其在糖尿病中的广泛治疗应用
Adv Pharm Bull. 2022 Aug;12(4):730-746. doi: 10.34172/apb.2022.075. Epub 2021 Oct 4.
8
Microencapsulation of lectin anti-cancer agent and controlled release by alginate beads, biosafety approach.微囊化凝集素抗癌剂并用藻酸盐珠进行控制释放,生物安全性方法。
Int J Biol Macromol. 2014 Aug;69:88-94. doi: 10.1016/j.ijbiomac.2014.05.031. Epub 2014 May 20.
9
Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.微囊化技术的最新进展:用于研究口服和透皮药物传递的体内和体外模型。
J Control Release. 2014 Mar 28;178:25-45. doi: 10.1016/j.jconrel.2013.12.028. Epub 2014 Jan 10.
10
Mathematical modeling of drug release from lipid dosage forms.从脂质剂型中释放药物的数学模型。
Int J Pharm. 2011 Oct 10;418(1):42-53. doi: 10.1016/j.ijpharm.2011.07.015. Epub 2011 Jul 23.

引用本文的文献

1
The eubiotic perspective on utilization of tannins in phytotherapy and nutrition of pigs.关于单宁在猪的植物疗法和营养中应用的正常微生物群视角。
Front Pharmacol. 2025 Aug 25;16:1649388. doi: 10.3389/fphar.2025.1649388. eCollection 2025.
2
Optimization of Solid Lipid Microcapsule Matrix for Enhanced Release and Bioavailability of L-Lysine in Swine.优化固体脂质微胶囊基质以提高猪体内L-赖氨酸的释放和生物利用度
Animals (Basel). 2025 Jun 19;15(12):1806. doi: 10.3390/ani15121806.
3
Fabricating Natural Polymeric Encapsules for Pest Control Uploaded with 1,8-Cineole Extracted from Eucalypt Ecotypes' Leaves Using Innovative Microwave Tool.

本文引用的文献

1
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines.用于增强DNA疫苗递送的分子工程化聚原酸酯微球。
Nat Mater. 2004 Mar;3(3):190-6. doi: 10.1038/nmat1075. Epub 2004 Feb 15.
2
Diagnostic microspheres: an overview.诊断微球:综述。
Crit Rev Ther Drug Carrier Syst. 2003;20(6):431-60. doi: 10.1615/critrevtherdrugcarriersyst.v20.i6.20.
3
Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres.将人免疫球蛋白G稳定化并封装到可生物降解的微球中。
利用创新微波工具制备用于害虫防治的天然聚合物胶囊,该胶囊负载从桉树种源叶片中提取的1,8-桉叶素。
Polymers (Basel). 2025 Apr 26;17(9):1182. doi: 10.3390/polym17091182.
4
Zinc nanoparticles mitigate azoxystrobin and its nanoencapsulation-induced hepatic and renal toxicity in rats.锌纳米颗粒减轻大鼠中嘧菌酯及其纳米包封物诱导的肝毒性和肾毒性。
Redox Rep. 2025 Dec;30(1):2491318. doi: 10.1080/13510002.2025.2491318. Epub 2025 Apr 20.
5
Dual Biopolymer Layer Using Nanoparticles with Active Substance Enclosed in Microcapsules: Innovative Solution for Slow Release of L. Extract for Potential Therapies.使用包裹有活性物质的纳米颗粒的双生物聚合物层微胶囊:用于潜在治疗的L提取物缓释创新解决方案。
Int J Mol Sci. 2025 Mar 27;26(7):3066. doi: 10.3390/ijms26073066.
6
Formulation of W/O/W Emulsion-Based Chitosan-Alginate Microcapsules for Encapsulation of Cannabidiol and L. Extract Containing Luteolin and Apigenin: A Response Surface Optimization Approach.用于包封大麻二酚及含木犀草素和芹菜素的L提取物的水包油包水型乳液基壳聚糖-海藻酸盐微胶囊的制备:响应面优化方法
Pharmaceutics. 2025 Feb 28;17(3):309. doi: 10.3390/pharmaceutics17030309.
7
High throughput microparticle production using microfabricated nozzle array.使用微加工喷嘴阵列进行高通量微粒生产。
RSC Adv. 2025 Mar 3;15(9):6823-6832. doi: 10.1039/d4ra09032b. eCollection 2025 Feb 26.
8
Therapeutic Potential of Medicinal Plants and Their Phytoconstituents in Diabetes, Cancer, Infections, Cardiovascular Diseases, Inflammation and Gastrointestinal Disorders.药用植物及其植物成分在糖尿病、癌症、感染、心血管疾病、炎症和胃肠道疾病中的治疗潜力。
Biomedicines. 2025 Feb 12;13(2):454. doi: 10.3390/biomedicines13020454.
9
Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective.用于糖尿病性视网膜病变的眼内给药系统:现状与未来展望。
Bioimpacts. 2024 May 19;15:30127. doi: 10.34172/bi.30127. eCollection 2025.
10
A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework.医学及其他领域中使用的纳米载体的系统评价——定义与分类框架
J Nanobiotechnology. 2025 Feb 7;23(1):90. doi: 10.1186/s12951-025-03113-7.
J Colloid Interface Sci. 2004 Mar 1;271(1):92-101. doi: 10.1016/j.jcis.2003.08.072.
4
Preparation and evaluation of microcapsules using polymerized rosin as a novel wall forming material.以聚合松香为新型壁材的微胶囊制备与评价
J Microencapsul. 2004 Feb;21(1):83-9. doi: 10.1080/02652040410001653768.
5
Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.含乙酰唑胺的聚丙烯酸树脂微球的制备及体外评价
Int J Pharm. 2004 Jan 9;269(1):131-40. doi: 10.1016/j.ijpharm.2003.09.015.
6
Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres.微球大小、沉淀动力学和药物分布控制着可生物降解聚酸酐微球的药物释放。
J Control Release. 2004 Jan 8;94(1):129-41. doi: 10.1016/j.jconrel.2003.09.011.
7
Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine.聚合物-药物相容性:抗癌药物玫瑰树碱递送系统开发指南
J Pharm Sci. 2004 Jan;93(1):132-43. doi: 10.1002/jps.10533.
8
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
9
Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.用于将肽和蛋白质微囊化到可生物降解聚酯中的超声雾化及随后的聚合物去溶剂化。
J Microencapsul. 2003 Sep-Oct;20(5):553-67. doi: 10.1080/0265204031000148059.
10
Effect of intragranular porosity on compression behaviour of and drug release from reservoir pellets.颗粒内孔隙率对储库型微丸压缩行为及药物释放的影响。
Eur J Pharm Sci. 2003 Aug;19(5):333-44. doi: 10.1016/s0928-0987(03)00106-4.